Hello Adreamer,
You posted a while back could MPL be effective as a treatment in long " brain " Covid. It has taken a while for me to sort this out due to cross referencing.
The rationale for MPL treating MND is different. Remembering , MPL is a very specific niche drug, but some uses are forgotten due cross treatments, if that makes sense .
https://www.deseret.com/coronavirus/2022/1/21/22894780/mild-covid-19-symptoms-brain-damage-side-effects
So that's today news article with a link to this study.
Mild respiratory SARS-Cov-2 infection can cause multi lineage cellular dysregulation and myelin loss in the brain . Fernandez et al 2022.
So Adreamer, if you then go to this next study you will go more in
as to cytokines actions in the brain causing neuroinfllamation.
The effects of Covid 19 on NF-kB and neurological manifestations . Davies et Al 2021
Adreamer you said there could be a link with MPL. Have a read of this to establish that. MPL is such a good drug. Don't let "anyone" sell it for less than what's it's worth. We have only scratched it's potential.
Very well done Adreamer in bringing it to our attention. A very big hand clap !
Monepantel exerts anti inflammatory properties in murine models macrophages with possible mediation through NF-kB signalling. Ataie et Al 2014.
- Forums
- ASX - By Stock
- PAA
- PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-289
- There are more pages in this discussion • 1,178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $91.02K | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 119713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 0.215 |
7 | 63630 | 0.210 |
4 | 193228 | 0.205 |
9 | 159603 | 0.200 |
4 | 276128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 119713 | 2 |
0.230 | 24215 | 3 |
0.235 | 50000 | 1 |
0.240 | 44200 | 1 |
0.245 | 55000 | 4 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.000 ( 5.72 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
Last updated 15.42pm 06/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online